Screening and characterization of myositis‐related autoantibodies in <scp>COVID</scp> ‐19 patients-Reference-Cited by-同舟云学术

Screening and characterization of myositis‐related autoantibodies in COVID ‐19 patients

Published:2022-10-27 Issue:1 Volume:16 Page:140-150
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Teo Kai‐Fa¹,Chen Der‐Yuan²³⁴,Hsu Jeh‐Ting⁵,Lai Yi‐Hua²⁴⁶,Chang Ching‐Kun³⁴,Hsueh Po‐Ren²⁷⁸⁹,Lan Joung‐Liang²⁴⁶,Hsu Jye‐Lin¹¹⁰^ORCID

Affiliation:

1. Graduate Institute of Biomedical Sciences China Medical University Taichung Taiwan

2. School of Medicine China Medical University Taichung Taiwan

3. Translational Medicine Laboratory China Medical University Hospital Taichung Taiwan

4. Rheumatology and Immunology Center China Medical University Hospital Taichung Taiwan

5. Department of Information Management Hsing Wu University New Taipei Taiwan

6. Rheumatic Diseases Research Center China Medical University Hospital Taichung Taiwan

7. Departments of Laboratory Medicine and Internal Medicine China Medical University Hospital Taichung Taiwan

8. Ph.D. Program for Aging, School of Medicine China Medical University Taichung Taiwan

9. Departments of Laboratory Medicine and Internal Medicine National Taiwan University Hospital, National Taiwan University College of Medicine Taipei Taiwan

10. Drug Development Center China Medical University Taichung Taiwan

Funder

China Medical University

China Medical University Hospital

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13434

Reference38 articles.

1. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2

2. COVID-19: consider cytokine storm syndromes and immunosuppression

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

4. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19

5. Idiopathic inflammatory myopathy patients with different autoantibody exhibit unique peripheral blood T cell subsets;Li J‐P;J Immunol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C);eBioMedicine;2024-06

2. The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review;Current Rheumatology Reports;2023-11-16

3. Skeletal muscle injury in COVID infection: Frequency and patterns;Muscle & Nerve;2023-10-20